Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Analyses of a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.

Harada D, Takada C, Tsukumo Y, Takaba K, Manabe H.

J Dermatol Sci. 2005 Mar;37(3):159-67. Epub 2004 Dec 31.

PMID:
15734285
2.
3.

Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models.

Harada D, Takada C, Nosaka Y, Takashima Y, Kobayashi K, Takaba K, Manabe H.

Int Immunopharmacol. 2009 Jan;9(1):55-62. doi: 10.1016/j.intimp.2008.09.011. Epub 2008 Oct 12.

PMID:
18854230
5.

Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen.

Nakada T, Watanabe K, Matsumoto T, Santa K, Triizuka K, Hanawa T.

Int Immunopharmacol. 2002 Jun;2(7):901-11.

PMID:
12188032
6.

Histamine H(4) receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge.

Seike M, Furuya K, Omura M, Hamada-Watanabe K, Matsushita A, Ohtsu H.

Allergy. 2010 Mar;65(3):319-26. doi: 10.1111/j.1398-9995.2009.02240.x. Epub 2009 Nov 2.

7.

A novel animal model of pruritus induced by successive application of glucocorticoid to mouse skin.

Yamaura K, Doi R, Suwa E, Ueno K.

J Toxicol Sci. 2011 Aug;36(4):395-401.

8.

Inhibitory effect of a potent and selective cytosolic phospholipase A2alpha inhibitor RSC-3388 on skin inflammation in mice.

Yamamoto M, Haruna T, Imura K, Hikita I, Furue Y, Higashino K, Gahara Y, Deguchi M, Yasui K, Arimura A.

Pharmacology. 2008;81(4):301-11. doi: 10.1159/000117816. Epub 2008 Feb 21.

PMID:
18287786
9.

Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice.

Sunada Y, Nakamura S, Kamei C.

Int Immunopharmacol. 2008 Dec 20;8(13-14):1761-6. doi: 10.1016/j.intimp.2008.08.011. Epub 2008 Oct 5.

PMID:
18790088
10.

GATA-3 regulates contact hyperresponsiveness in a murine model of allergic dermatitis.

Tamauchi H, Amoh Y, Itoh M, Terashima M, Masuzawa M, Habu S, Katsuoka K, Iwabuchi K.

Immunobiology. 2012 Apr;217(4):446-54. doi: 10.1016/j.imbio.2011.10.009. Epub 2011 Nov 6.

PMID:
22112437
11.

Anti-inflammatory effects of sacran, a novel polysaccharide from Aphanothece sacrum, on 2,4,6-trinitrochlorobenzene-induced allergic dermatitis in vivo.

Ngatu NR, Okajima MK, Yokogawa M, Hirota R, Eitoku M, Muzembo BA, Dumavibhat N, Takaishi M, Sano S, Kaneko T, Tanaka T, Nakamura H, Suganuma N.

Ann Allergy Asthma Immunol. 2012 Feb;108(2):117-22. doi: 10.1016/j.anai.2011.10.013. Epub 2011 Nov 29.

PMID:
22289731
12.
13.
14.

Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice.

Tamura T, Matsubara M, Takada C, Hasegawa K, Suzuki K, Ohmori K, Karasawa A.

Br J Dermatol. 2004 Dec;151(6):1133-42.

PMID:
15606507
15.
16.

Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice.

Kang JS, Lee K, Han SB, Ahn JM, Lee H, Han MH, Yoon YD, Yoon WK, Park SK, Kim HM.

Int Immunopharmacol. 2006 Oct;6(10):1616-22. Epub 2006 Jul 18.

PMID:
16919834
20.

A new chronic itch model accompanied by skin lesions in hairless mice.

Ueda Y, Inoue T, Rahman MA, Yatsuzuka R, Jiang S, Kamei C.

Int Immunopharmacol. 2006 Oct;6(10):1609-15. Epub 2006 Jul 3.

PMID:
16919833

Supplemental Content

Support Center